GlassScriptPhysician profile
Amy N Belott
NPI 1821455080
$1,739.67
in general payments reported to CMS, 2019-2025
10 companies · $33.37 in 2025
The $33.37 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.55 · 2022: $405 · 2023: $221 · 2024: $1,035 · 2025: $33.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,006 · Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,006.39 |
| Food and Beverage | $282.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,034.65 | 2024 | |
| Inari Medical, INC. | $215.41 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Smith+Nephew, INC. | $184.13 | 2022-2023 | Pico 7, Renasys Go V2 Home |
| W. L. Gore & Associates, INC. | $122.34 | 2022 | |
| Janssen Pharmaceuticals, INC | $45.55 | 2021 | |
| Novartis Pharmaceuticals Corporation | $43.55 | 2022 | |
| Kci USA, INC. | $37.10 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.57 | 2022 | |
| Amphastar Pharmaceuticals, INC. | $17.91 | 2025 | |
| Merck Sharp & Dohme LLC | $15.46 | 2025 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Belott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.